ישראל - עברית - Ministry of Health

unipharm ltd, israel - olanzapine - טבליות מצופות פילם - olanzapine 7.5 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. zappa is indicated for the management of the manifestations of psychotic disorders. zappa is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment zappa is indicated for the prevention of reccurence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of zappa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

ישראל - עברית - Ministry of Health

unipharm ltd, israel - olanzapine - טבליות מצופות פילם - olanzapine 10 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. zappa is indicated for the management of the manifestations of psychotic disorders. zappa is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment zappa is indicated for the prevention of reccurence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of zappa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

ישראל - עברית - Ministry of Health

unipharm ltd, israel - olanzapine - טבליות מסיסות בפה - olanzapine 5 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. zappa odt is indicated for the management of the manifestations of psychotic disorders. zappa odt is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder : in patients whose manic episode has responded to olanzapine treatment zappa odt is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of zappa odt with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

ישראל - עברית - Ministry of Health

unipharm ltd, israel - olanzapine - טבליות מסיסות בפה - olanzapine 10 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. zappa odt is indicated for the management of the manifestations of psychotic disorders. zappa odt is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder : in patients whose manic episode has responded to olanzapine treatment zappa odt is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of zappa odt with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 80 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. note: symbicort turbuhaler 80/4.5 mcg/dose is not appropriate in patients with severe asthma.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 160 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - asthma symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents age 12 years and above where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. or - patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 320 mcg/dose; formoterol fumarate 9 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents (over the age of 12 years) where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - loteprednol etabonate; tobramycin - תרחיף לעין - tobramycin 3 mg/ml; loteprednol etabonate 5 mg/ml - tobramycin - tobramycin - zylet is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies.the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.the particular anti-infect

ישראל - עברית - Ministry of Health

rekah pharmaceutical industry ltd, israel - bacitracin; neomycin as sulfate; polymyxin b sulfate - משחה לעין - bacitracin 400 u/g; polymyxin b sulfate 5000 u/g; neomycin as sulfate 5 mg/g - antibiotics in combination with other drugs - antibiotics in combination with other drugs - short term treatment of superficial external ocular infections caused by organisms susceptible to one or more of the antibiotics contained therein.

ישראל - עברית - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.